This bill would require that a hospital shall maintain a metal detector at each point of entry into the hospital.
HB4146 prevents the modification of a health insurance plan’s prescription drug formulary during a plan year if a drug has been previously approved for coverage, a prescriber continues to prescribe the drug and a patient continues to be an enrollee of a healthcare plan. The legislation blocks cost containment options that a health insurance plan or pharmacy benefits manager can currently utilize, such as removing a prescription drug from a formulary, moving a drug to a more restrictive tier or increasing cost-sharing arrangements. These changes typically occur when a similar, more cost-effective drug enters the marketplace.
This legislation expanded the scope of practice for physical therapists to include dry needling. The Chamber successfully negotiated language that would ensure that employers do not have to cover the experimental treatment.
Creates the independent quasi-judicial Health Insurance Rate Review Board to ensure insurance rates are reasonable and justified. Sets forth duties and prohibited activities concerning the Board. Provides that the Board shall review and approve or disapprove all rates and rate schedules filed or used by a health carrier. Sets forth provisions concerning rate standards, public notice, hearings, and the disapproval and approval of rates and rate schedules.
This bill is a pre-existing condition insurance mandate, passed by both houses. The bill as passed, adopted an amendment that clarified the mandate did not apply to short-term travel, disability income, long-term care, accident only, or limited or specified disease policies.
Insurance mandate on hearing instruments.
Amends the Illinois Insurance Code, the State Employees Group Insurance Act of 1971, the Counties Code, the Illinois Municipal Code, the School Code, the Health Maintenance Organization Act, the Limited Health Service Organization Act, and the Voluntary Health Services Plans Act. Prohibits insurers from requiring that a covered individual first use an opioid analgesic drug product without abuse-deterrence labeling claims before providing coverage for an abuse-deterrent opioid analgesic drug product.